Bryan Johnson Tracks Girlfriend’s Clitoral Blood Flow: What Can It Reveal About Her Cardiovascular & Sexual Health - Health and Me

DennySo apparently this happened: Bryan Johnson Tracks Girlfriend’s Clitoral Blood Flow: What Can It Reveal About Her Cardiovascular & Sexual Health. I need your honest reaction to it.

FarrahYou’re calling a guy tracking a partner’s private physiology “health innovation,” but honestly, that looks like surveillance dressed up in wellness clothes. Most people don’t even realize they have nocturnal erections until someone points it out, let alone consent to having them scored on a phone app. There’s a massive gap between noticing a biological signal and turning a relationship dynamic into a data dashboard.

DennyWait, hold on—the fact that the clitoris uses the same erectile tissue as a man means those nocturnal spikes are literally a window into her vascular system. If that signal drops off, she might be dealing with circulation issues years before any doctor catches it. That’s not just creepy monitoring; it’s early detection for a problem we usually ignore in women.

FarrahBut he hasn't shown us a single baseline for Kate, so claiming a drop-off predicts disease is pure speculation right now. He knows his own average is three hours a night because he has years of data; applying that metric to his girlfriend assumes her body works exactly like his, which is a huge leap. Without knowing what "normal" looks like for her specifically, that Tier-1 marker label is just borrowed authority from male health stats.

DennyPicture a couple where the wife notices her energy fading during sex while the husband feels totally fine, yet neither mentions it at their checkup. Tracking that blood flow over time could catch the mismatch weeks before either of them realizes the plumbing is clogged. That specific timeline difference is exactly why relying on how someone feels leaves too much room for missed warnings.

FarrahPicture someone whose partner starts logging every meal and step in a shared app, claiming it’s for heart health, while the logged person has no idea what “good” looks like for their own metabolism. That kind of constant scoring turns intimacy into performance review, where the only feedback loop is numerical rather than emotional connection. The device costs two hundred seventy-five dollars, but the cost of making someone feel monitored inside their own bedroom isn’t priced into that tag.

DennyTwo hundred seventy-five dollars buys a wireless sensor that scores each spike automatically, removing the guesswork from whether her vessels are actually opening. That automated log is the missing piece no human observer can replicate.

FarrahAutomated logging does strip away the embarrassment of asking a patient to count their sleep cycles, which is a real barrier to getting accurate data. Still, a $275 gadget generating numbers doesn’t replace the clinical context needed to interpret them, since individual anatomy varies widely enough that raw frequency says little without a physical exam. We’re still guessing what a healthy range looks like for Kate specifically, not comparing her to some generic female chart.

DennyIndividual anatomy variation is a fair point that kills the generic chart comparison, but the core issue is that no one is measuring anything at all in most women’s lives. That complete absence of data means we have no reference point to spot when something actually changes, leaving the entire diagnostic process blind until symptoms become severe. The wirefree setup removes the friction of manual tracking, which is the main reason these signals go unrecorded in the first place.

FarrahCalling total silence “blindness” is like saying a library is empty because nobody is shouting. Sure, having zero records makes spotting change harder, but assuming a $275 sensor fixes that ignores that we don’t even know which fluctuations matter versus normal nightly variance. Until a clinician confirms what Kate’s actual baseline should be, that automatic score is just a very expensive guess wrapped in tech optimism.

DennyYou're stuck on the medical interpretation, but think about the woman receiving the data—she finally sees proof that her body responds predictably, which reframes arousal as biology rather than mood. For a lot of people who assume they're broken, seeing those consistent REM spikes on a phone screen shifts the internal narrative from guilt to mechanics.

FarrahShifting the narrative requires her consent to view the screen, not just your assumption that she needs saving. You cannot reframe someone else's experience as a mechanical problem based on a single week of readings.

DennyA single week of data is indeed thin evidence, but consider the parallel Bryan already established with his own four-to-five nightly erections averaging three hours. If he validates that his vascular markers align with known cardiac risk windows, applying the same logic to Kate creates a comparable predictive model rather than a random guess. The pattern matters more than the initial sample size here.

FarrahYour own erection timing doesn't validate hers because male and female erectile physiology operate under different hormonal and structural constraints. Comparing his three-hour average to her readings assumes a universal vascular clock that simply isn't supported by current anatomical models. We need independent validation for her specific tissue response before calling it a reliable predictive marker.

DennyMale erectile dysfunction flags heart issues years early, yet we treat female vascular health as a black box until pain appears. Tracking her nocturnal tumescence gives us the exact lead time window we lack elsewhere. It’s the only way to catch a silent blockage while it’s still reversible.

FarrahCatching a blockage early sounds great, but we do not actually know that clitoral flow predicts heart disease the way penile rigidity might, so claiming reversibility rests on an analogy, not a dataset. Without that specific link proven, the device is just expensive monitoring of normal sleep function, not a medical alarm. Let’s stop treating a biological curiosity like a life-saving diagnostic tool before the evidence catches up.

DennyI’ll grant that the direct cardiac link remains unproven for her, but if we wait for a confirmed diagnosis, we lose the exact window where intervention might still work. The $275 cost buys us the only continuous data we’ve never had on female vascular decline, so the real question isn’t whether the app is a perfect hospital monitor, but whether ignoring those numbers leaves us blind to risks that are currently invisible.